In addition, it was found that mice with underlying NAFLD and who were treated with MC had a notably higher abundance of lactate-producing bacteria than the corresponding control group, which was associated with elevated NOX2 in the MC-exposed mice. The gene discussed is CYBB; the disease is metabolic dysfunction-associated steatotic liver disease.